Praxis Precision Medicines, Inc. PRAX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $77.99M+28.3% | $77.51M+37.7% | $65.8M+57.1% | $63.01M+131% | $60.81M+125% | ||
| $27.87M+100% | $19.54M+29.1% | $12.56M-17.7% | $13.06M+23.4% | $13.92M-9.2% | ||
| $105.86M+41.7% | $97.04M+35.9% | $78.36M+37.1% | $76.07M+101% | $74.73M+76.6% | ||
| $105.86M+41.7% | $97.04M+35.9% | $78.36M+37.1% | $76.07M+101% | $74.73M+76.6% | ||
| -$105.86M-41.7% | -$97.04M-51.7% | -$78.36M-37.9% | -$76.07M-103% | -$74.73M-78.4% | ||
| $13.3M+145% | $8.13M+54.1% | $4.43M-10.2% | $4.94M+2.7% | $5.43M+133% | ||
| -$92.56M-33.6% | -$88.91M-51.5% | -$73.93M-42.4% | -$71.13M-118% | -$69.3M-75.2% | ||
| -$3.20+2.7% | -$3.51-17.0% | -$3.36-22.2% | -$3.31-90.2% | -$3.29-15.8% | ||
| -$3.20+2.7% | -$3.51-17.0% | -$3.36-22.2% | -$3.31-90.2% | -$3.29-15.8% | ||
| 28.9M+37.2% | 22.5M+25.7% | 22M+16.4% | 21.5M+14.1% | 21.1M+51.4% | ||
| 28.9M+37.2% | 22.5M+25.7% | 22M+16.4% | 21.5M+14.1% | 21.1M+51.4% | ||
| $13.3M+145% | $8.13M+54.1% | $4.43M-10.2% | $4.94M+2.7% | $5.43M+133% | ||
| -$105.86M-41.7% | -$97.04M-51.7% | -$78.36M-37.9% | -$76.07M-103% | -$74.73M-78.4% | ||
| -$105.82M-41.7% | -$97.02M-51.8% | -$78.34M-38.1% | -$76.02M-103% | -$74.68M-78.8% | ||
| -$105.82M-41.7% | -$97.02M-51.8% | -$78.34M-38.1% | -$76.02M-103% | -$74.68M-78.8% | ||
| -$105.86M-41.7% | -$97.04M-51.7% | -$78.36M-37.9% | -$76.07M-103% | -$74.73M-78.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Praxis Precision Medicines, Inc. profitable?
- Praxis Precision Medicines, Inc. is not currently profitable: it reported a net loss of $326.5M over the trailing twelve months, a -3658.5% net margin.
- What is Praxis Precision Medicines, Inc.'s earnings per share?
- Praxis Precision Medicines, Inc.'s diluted EPS over the trailing twelve months is $-13.38.
- Where does Praxis Precision Medicines, Inc.'s income statement data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.